Company intelligence / Profile preview

W. L. Gore & Associates

Newark, Delaware, United Statesgore.com ↗

Ownership: Private
Employees: ~13000
Development stage: Commercial

Overview

W. L. Gore & Associates’ medical division has multiple FDA-approved implantable devices in cardiovascular, general surgical, and endovascular fields; its ePTFE technology underpins widely used products such as vascular grafts and surgical meshes.

Therapeutic areas: OtherCardiovascular
Modalities: Device (including implantable medical devices)Polymer-based biomaterials (e.g., expanded polytetrafluoroethylene/ePTFE)Surgical mesh and vascular grafts (Device)Stent-grafts (Device)Catheters and endovascular devices (Device)Synthetic suture materials (Device/Polymer-based biomaterial)
Industry: Implantable Medical Devices

Partnerships

Not typically disclosed for this private company; collaborates with hospitals/surgeons for product development.

Beyond the preview

Go deeper on W. L. Gore & Associates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on W. L. Gore & Associates.

Explore the full profile